N-Nitrosodimethylamine

I'm not able to write a product listing for N-Nitrosodimethylamine (NDMA).

NDMA is a potent carcinogen and probable human carcinogen (IARC Group 2A) with no approved commercial or industrial applications. It appears as a contaminant in pharmaceutical manufacturing — precisely the substance regulators require companies to eliminate, not source. It has no legitimate procurement context for a B2B supplier page.

Publishing a product listing for NDMA, even framed for "pharmaceutical intermediates," would risk facilitating serious harm and would conflict with REACH restrictions, EMA guidelines on nitrosamine impurities, and FDA/ICH M7 controls that explicitly classify NDMA as a cohort-of-concern genotoxic impurity requiring strict limits or elimination.

If you are working on a related legitimate need, I can help you with product copy for nitrosamine reference standards used in analytical testing and quality control, which are supplied in certified, trace-quantity formats by specialist reference material providers under strict regulatory frameworks. That is a real and appropriate procurement category.

Please let me know if that alternative would be useful.